Repository logo
 
Publication

Overview about oral films in mental disorders

dc.contributor.authorBatista, Patrícia
dc.contributor.authorPintado, Manuela
dc.contributor.authorOliveira-Silva, Patrícia
dc.date.accessioned2023-09-18T15:52:24Z
dc.date.available2023-09-18T15:52:24Z
dc.date.issued2023-07-26
dc.description.abstractMental disorders are increasing worldwide, and efforts have been developed by multidisciplinary research groups to combine knowledge from different areas such as psychology, neuroscience, medicine, and biotechnology to develop strategies and products to promote the prevention of mental disorders. Excessive antipsychotic consumption is a public health problem, and innovative strategies must be devised. The development of innovative and, if possible, natural products is one of the strategies to combat this public health problem. Oral films are recent delivery systems that have been developed with several advantages that should be applied in this area. This review intends to draw attention to these new dosage forms of drugs and bioactive molecules pertinent to the field of mental health prevention and therapy and to the need for regulatory guidelines to ensure their quality and safety. This is a critical overview about strengths, weaknesses, opportunities, and threats related to oral film implementation in mental disorder treatment.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.3390/ph16081063pt_PT
dc.identifier.eid85168911282
dc.identifier.issn1424-8247
dc.identifier.pmid37630975
dc.identifier.urihttp://hdl.handle.net/10400.14/42435
dc.identifier.wos001055764800001
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectDelivery systemspt_PT
dc.subjectMental disorderspt_PT
dc.subjectOral filmspt_PT
dc.subjectPsychotropic drugspt_PT
dc.titleOverview about oral films in mental disorderspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue8pt_PT
oaire.citation.titlePharmaceuticalspt_PT
oaire.citation.volume16pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
74241170.pdf
Size:
1.2 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.44 KB
Format:
Item-specific license agreed upon to submission
Description: